r version 4 2 2 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
r version 4 2 2
R Version 4 2 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+version+2+12+0/STATA+12%2E0/pm39440782-103-7-11
Average 99 stars, based on 36686 article reviews
R Version 4 2 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+version+2+12+0/STATA+12%2E0/pm39440782-103-7-11
Average 99 stars, based on 36686 article reviews
r version 4 2 2 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Validation of Self-Reported Smokeless Tobacco Use by Measurement of Serum Cotinine Concentration Among US Adults Article Snippet: All analyses were conducted using Article Title: A wide-spectrum paired comparison of the properties of the Rolling 6 and 3+3 Phase I study designs. Article Snippet: Article history: Received 4 December 2010 Received in revised form 24 March 2011 Accepted 21 April 2011 Available online 29 April 2011 The recently proposed Rolling 6 Phase I study design is an alternative to the standard 3+3 patient cohort design.. It was proposed as a way to reduce the time necessary to complete a trial by reducing the downtime during which Phase I trials are suspended for evaluation of doselimiting toxicity (DLT).. We performed a paired comparison of the Rolling 6 and 3+3 designs via a large simulation study over a wide spectrum of conditions defined by inter-patient arrival time, number of doses, DLT dose response slope, DLT dose response shape, and starting dose. Article Title: Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Article Snippet: Several studies have investigated the frequency of familial dilated cardiomyopathy (FDC).. However, no systematic review and meta-analysis on this topic are available.. Therefore, using the PubMed, MEDLINE, Cochrane, and the ISI Web of Science databases, relevant reports published through December 2010 were identified. Article Title: Prescribing of nicotine replacement therapy to cardiovascular disease patients in England. Article Snippet: Aims In November 2005 the indications for nicotine replacement therapy (NRT) were broadened in the United Kingdom, making all forms available to patients with stable cardiovascular disease (CVD).. This study aimed to estimate the effects of this change on prescribing of NRT to CVD patients in England.. Design Segmented regression analysis of time series of monthly rates of prescribing of NRT. |